HEMMER DER VERZWEIGTENAMINOSÄURE-ABHÄNGIGEN AMINOTRANSFERASE UND DEREN VERWENDUNG IN DER BEHANDLUNG VON NEURODEGENERATIVEN ERKRANKUNGEN

The invention relates to BCAT inhibitor compounds of formula (I) and use thereof for treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral scl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HU, LAIN-YEN, WUSTROW, DAVID, JUERGEN, BORA, KEENAN, MARTIN, LEI, HUANYSHU, MORELAND, DAVID, WINSLOW, RAFFERTY, MICHAEL, FRANCIS, RYDER, TODD, ROBERT, KESTEN, SUZANNE, ROSS, SCHOLTEN, JEFFREY, DAVID
Format: Patent
Sprache:ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to BCAT inhibitor compounds of formula (I) and use thereof for treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the overstimulation of the excitatory amino acids, treating anxiety, psychosis, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine headache, chronic pain, neuropathic pain, Parkinson's disease, diabetic retinopathy, glaucoma, CMV retinitis, urinary incontinence, opioid tolerance or withdrawal, and inducing anesthesia, as well as for enhancing cognition.